ProbioMax IG 26 DF By XYMOGEN Overview & Drug Interactions
Check For Interactions With ProbioMax IG 26 DF
Supplement: ProbioMax IG 26 DF by XYMOGEN
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Calories
Ingredient Group | Header |
---|---|
Category | other |
Cholesterol
Ingredient Group | Cholesterol |
---|---|
Category | fat |
Sodium
Ingredient Group | Sodium |
---|---|
Category | mineral |
IgY Max hyperimmunized Egg powder
Ingredient Group | Egg |
---|---|
Category | animal part or source |
LactoSpore Bacillus coagulans MTCC5856
Bacillus coagulans, also known as Weizmannia coagulans or Lactobacillus sporogenes, is a spore-forming, lactic acid-producing, Gram-positive bacterium used as a probiotic. Bacillus coagulans has shown benefits for constipation and irritable bowel syndrome (IBS). Its spores are stable in stomach acid and reach the small intestine, where they germinate and multiply, with around 85% reaching their destination. The bacterium is excreted via feces, with spores detectable up to 7 days post-administration. Mechanistically, Bacillus coagulans exhibits antibacterial effects through the production of coagulin, lactic acid, and lactosporin, reducing pathogenic bacteria colonization. It also demonstrates antifungal properties and anti-inflammatory effects, potentially reducing the growth of pathogenic bacteria and decreasing the production of lipopolysaccharides. Bacillus coagulans may stimulate immune response, as evidenced by increased CD4+ T cells in adults with HIV-1 infection and modulation of inflammatory cytokines in schoolchildren. These properties categorize Bacillus coagulans as an immunomodulator, immunostimulant, and probiotic, with potential therapeutic applications in promoting digestive health and immune function.
See More Information Regarding Bacillus CoagulansIngredient Group | Bacillus Coagulans |
---|---|
Category | bacteria |
Drugs that interact with ProbioMax IG 26 DF by XYMOGEN
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
2 Capsule(s)
|
Maximum serving Sizes: |
2 Capsule(s)
|
Servings per container | 60 |
UPC/BARCODE | 871149001612 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Calories |
5 Calorie(s)
|
Header |
|
Cholesterol |
15 mg
|
Cholesterol |
5%
|
Sodium |
5 mg
|
Sodium |
1%
|
IgY Max hyperimmunized Egg powder |
1 Gram(s)
|
Egg |
--
|
LactoSpore Bacillus coagulans MTCC5856 |
10 mg
|
Bacillus Coagulans |
--
|
Other Ingredients: |
HPMC
Medium-Chain Triglyceride Oil
Silica
Dicalcium Phosphate
Sweet Potato Maltodextrin
|
---|
Label Statments:
General Statements |
- Professional use only
- In addition to its research-supported role in promoting healthy bacterial balance in the gut, this strain has been studied for its effects on maintaining blood lipid levels already within a healthy range and its effect on vaginal health.
- Systemic health support via gut health
- ePV
Exclusive professional formulas
- Scan to learn more!
This package is completely recyclable
|
---|---|
Brand IP Statement(s) |
- Not for resale on third-party websites, including, but not limited to, Amazon and eBay.
- ProbioMax IG 26 DF features clinically validated ingredients to support microbiome wellness and overall immune health. LactoSpore (Bacillus coagulans MTCC5856) is a unique strain of shelf-stable L (+) lactic acid-producing bacteria with a naturally protective spore coating.
- IG 26 DF (IgY Max), hyperimmunized egg powder, provides immunoglobulins and immune cofactors to support the body's natural defenses by limiting non-beneficial microbial adhesion.
- IgY Max
IgY Max is a trademark of IgY Nutrition, LLC and is used under license.
- LactoSpore is a registered trademark of Sabinsa Corp.
- 2017 XYMOGEN
|
Suggested/Recommended/Usage/Directions |
- Directions: Take two capsules twice daily with cold water, or as directed by your healthcare practitioner.
|
Precautions |
- Consult your healthcare practitioner prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare practitioner, and individuals with egg allergies should not consume this product.
- Individuals taking medication should discuss potential interactions with their healthcare practitioner, and individuals with egg allergies should not consume this product.
- Do not use if tamper seal is damaged.
- Storage: Keep closed in a cool, dry place out of reach of children.
- Contains: Egg
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Storage |
- Storage: Keep closed in a cool, dry place out of reach of children.
|
Formulation |
- Does Not Contain: Wheat, gluten, yeast, corn, soy, dairy products, fish, shellfish, peanuts, tree nuts, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
|
FDA Statement of Identity |
- Dietary Supplement
|
Formula |
- Contains: Egg
|
General |
- ZLB-PMIG26-01 REV. 060717
|
Seals/Symbols |
- Vegetarian caps
- Third-Party GMP Compliant Verified
|
Brand Information
See all products by this brand
Manufacturer | |
---|---|
Name | XYMOGEN Exclusive Professional Formulas |
Street Address | 6900 Kingspointe Pkwy. |
City | Orlando |
State | FL |
ZipCode | 32819 |
Phone Number | 800-647-6100 |
Web Address | www.xymogen.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.